Alpha-Adrenoreceptor Binding on Facial Vessels
Placeholder: agonists dock onto alpha-1 and alpha-2 receptors on vessel walls.
- α1/α2: Target receptor (Placeholder subtype note)
- α2-selective: Brimonidine affinity (Placeholder affinity note)
- α1-selective: Oxymetazoline affinity (Placeholder affinity note)
- Minutes: Onset (Placeholder onset note)
Receptor pharmacology basics
Placeholder: short note on receptor subtype binding kinetics.
Rapid Smooth-Muscle Vasoconstriction
Placeholder: receptor activation triggers vessel wall smooth muscle contraction.
- ~5-15 min: Onset speed (Placeholder speed note)
- 1-3 hrs: Peak effect (Placeholder peak note)
- ↓ sharply: Vessel diameter (Placeholder diameter note)
- Gi/Gq signaling: Mechanism (Placeholder mechanism note)
Signaling to contraction
Placeholder: brief note on second-messenger contraction cascade.
Temporary Reduction of Visible Facial Redness
Placeholder: reduced blood flow lowers visible redness for several hours.
- ~6 hrs: Duration (brimonidine) (Placeholder duration note)
- ~12 hrs: Duration (oxymetazoline) (Placeholder duration note)
- Cosmetic only: Redness masked (Placeholder scope note)
- Rosacea erythema: Common use (Placeholder use note)
Duration of visible effect
Placeholder: short note on how long redness stays reduced.
Wear-off and Rebound Flushing Risk
Placeholder: as drug clears, vessels can dilate beyond baseline redness.
- Late hours: Rebound window (Placeholder window note)
- Receptor downregulation: Risk driver (Placeholder driver note)
- Variable: Severity (Placeholder severity note)
- Limit frequency: Mitigation (Placeholder mitigation note)
Why rebound happens
Placeholder: short note on tachyphylaxis and rebound vasodilation.
Cosmetic Masking vs Disease-Modifying Treatment
Placeholder: these agents mask symptoms, not the underlying rosacea process.
- No: Disease-modifying? (Placeholder distinction note)
- Unaddressed: Underlying cause (Placeholder cause note)
- Anti-inflammatory tx: Complementary care (Placeholder care note)
- Temporary effect: Patient expectation (Placeholder expectation note)
Setting realistic expectations
Placeholder: short note distinguishing symptom relief from cure.
Placeholder: these drugs treat appearance, not rosacea pathology.